An integrated analysis of three medulloblastoma clinical trials refines risk-stratification approaches for reducing toxicity and improving survival
对三项髓母细胞瘤临床试验的综合分析，改进了风险分层方法，以降低毒性并提高生存率。
期刊:Neuro-Oncology
影响因子:13.4
doi:10.1093/neuonc/noaf250
Smith, Kyle S; Dhanda, Sandeep K; Billups, Catherine A; Sioson, Edgar; Lu, Congyu; Peraza, Airen Zaldivar; Gangwani, Karishma; Li, Yimei; Li, Qian; Lin, Tong; Michalski, Jeff M; Packer, Roger J; Olson, James M; Leary, Sarah E S; Fouladi, Maryam; Gajjar, Amar; Zhou, Xin; Onar-Thomas, Arzu; Northcott, Paul A; Robinson, Giles W
